Top movers in Tuesday's session Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.
Most active stocks in Tuesday's session Let's have a look at what is happening on the US markets on Tuesday. Below you can find the most active stocks in today's session.
RLYB Stock Earnings: Rallybio Beats EPS for Q1 2024 RLYB stock results show that Rallybio beat analyst estimates for earnings per share the first quarter of 2024.
What's going on in today's session Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Gapping stocks in Tuesday's session In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down.
Why Is Microcap Rallybio Stock Trading Higher On Tuesday? Rallybio sells its stake in preclinical HPP drug REV102 to Recursion in a deal worth up to $25 million, including equity and milestone payments.
Which stocks have an unusual volume on Monday? Unusual volume stocks are being observed in Monday's session.
Rallybio Stock Plunges After Program For Pediatric Bleeding Disorder Disappoints Rallybio ends RLYB212 trial for FNAIT; shifts focus to RLYB116 and preclinical assets with 2025 trial milestones and $6 billion market potential.
RLYB Stock Earnings: Rallybio Misses EPS for Q2 2024 RLYB stock results show that Rallybio missed analyst estimates for earnings per share the second quarter of 2024.
3 Sorry Biotech Stocks to Sell in May While You Still Can Morgan Stanley's bullish outlook highlights the need for strategic trimming of underperforming biotech stocks to sell.
3 Biotech Stocks to Sell in May Before They Crash & Burn Discover essential insights on biotech stocks to sell in May to navigate market volatility and safeguard your investment portfolio.
